Personalized monitoring of electrical remodelling during atrial fibrillation progression via remote transmissions from implantable devices.

Atrial fibrillation Atrial fibrillation progression Electrical remodeling Implantable cardioverter-defibrillator Mobile health Telemedicine eHealth

Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 05 03 2019
accepted: 12 11 2019
pubmed: 17 12 2019
medline: 29 6 2021
entrez: 17 12 2019
Statut: ppublish

Résumé

Atrial electrical remodelling (AER) is a transitional period associated with the progression and long-term maintenance of atrial fibrillation (AF). We aimed to study the progression of AER in individual patients with implantable devices and AF episodes. Observational multicentre study (51 centres) including 4618 patients with implantable cardioverter-defibrillator +/-resynchronization therapy (ICD/CRT-D) and 352 patients (2 centres) with pacemakers (median follow-up: 3.4 years). Atrial activation rate (AAR) was quantified as the frequency of the dominant peak in the signal spectrum of AF episodes with atrial bipolar electrograms. Patients with complete progression of AER, from paroxysmal AF episodes to electrically remodelled persistent AF, were used to depict patient-specific AER slopes. A total of 34 712 AF tracings from 830 patients (87 with pacemakers) were suitable for the study. Complete progression of AER was documented in 216 patients (16 with pacemakers). Patients with persistent AF after completion of AER showed ∼30% faster AAR than patients with paroxysmal AF. The slope of AAR changes during AF progression revealed patient-specific patterns that correlated with the time-to-completion of AER (R2 = 0.85). Pacemaker patients were older than patients with ICD/CRT-Ds (78.3 vs. 67.2 year olds, respectively, P < 0.001) and had a shorter median time-to-completion of AER (24.9 vs. 93.5 days, respectively, P = 0.016). Remote transmissions in patients with ICD/CRT-D devices enabled the estimation of the time-to-completion of AER using the predicted slope of AAR changes from initiation to completion of electrical remodelling (R2 = 0.45). The AF progression shows patient-specific patterns of AER, which can be estimated using available remote-monitoring technology.

Identifiants

pubmed: 31840163
pii: 5678518
doi: 10.1093/europace/euz331
pmc: PMC7203636
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

704-715

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL122352
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Circ Arrhythm Electrophysiol. 2016 Feb;9(2):e003354
pubmed: 26823480
Heart Rhythm. 2016 Dec;13(12):2279-2286
pubmed: 27544748
JACC Basic Transl Sci. 2016 Apr;1(3):143-154
pubmed: 27525318
J Am Coll Cardiol. 2010 Feb 23;55(8):725-31
pubmed: 20170808
Circ Res. 2019 Aug 30;125(6):609-627
pubmed: 31366278
Circ Cardiovasc Qual Outcomes. 2011 May;4(3):313-20
pubmed: 21540439
Heart Rhythm. 2011 Feb;8(2):181-7
pubmed: 21034858
Am J Cardiol. 2002 Nov 1;90(9):1011-4
pubmed: 12398975
Circulation. 2014 Apr 8;129(14):1472-82
pubmed: 24463369
Circulation. 2018 Mar 6;137(10):1027-1038
pubmed: 29129827
Open Heart. 2015 Jun 08;2(1):e000223
pubmed: 26082844
Heart Rhythm. 2016 May;13(5):1020-1027
pubmed: 26776554
Heart Rhythm. 2009 Oct;6(10):1415-22
pubmed: 19656731
IEEE Trans Biomed Eng. 2015 Jan;62(1):296-302
pubmed: 25148659
Circulation. 2007 May 22;115(20):2606-12
pubmed: 17502567
JAMA Cardiol. 2017 Oct 1;2(10):1120-1127
pubmed: 28842973
Biophys J. 2008 Nov 1;95(9):4469-80
pubmed: 18658226
Rev Esp Cardiol. 2007 Feb;60(2):104-9
pubmed: 17338875
Europace. 2016 Nov;18(11):1609-1678
pubmed: 27567465
Circulation. 2007 Dec 4;116(23):2702-8
pubmed: 18025528

Auteurs

José María Lillo-Castellano (JM)

Advanced Development in Arrhythmia Mechanisms and Therapy Laboratory, Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Fundación Interhospitalaria para la Investigación Cardiovascular (FIC), Madrid, Spain.

Juan José González-Ferrer (JJ)

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC). Cardiovascular Institute, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Manuel Marina-Breysse (M)

Advanced Development in Arrhythmia Mechanisms and Therapy Laboratory, Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Agencia Española de Protección de la Salud en el Deporte (AEPSAD), Madrid. Spain.

José Bautista Martínez-Ferrer (JB)

Department of Cardiology, Hospital Universitario de Áraba, Vitoria, Spain.

Luisa Pérez-Álvarez (L)

Department of Cardiology, Hospital Hospital Universitario de A Coruña, La Coruña, Spain.

Javier Alzueta (J)

Department of Cardiology, Hospital Universitario Virgen de la Victoria, Málaga, Spain.

Juan Gabriel Martínez (JG)

Department of Cardiology, Hospital General Universitario de Alicante, ISABIAL-FISABIO, Alicante, Spain.

Aníbal Rodríguez (A)

Department of Cardiology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.

Juan Carlos Rodríguez-Pérez (JC)

Department of Cardiology, Hospital Insular de Gran Canaria, Las Palmas, Spain.

Ignasi Anguera (I)

Department of Cardiology, Hospital Universitario de Bellvitge, Barcelona, Spain.

Xavier Viñolas (X)

Department of Cardiology, Hospital Santa Creu i san Pau, Barcelona, Spain.

Arcadio García-Alberola (A)

Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, IMIB, Murcia, Spain.

Jorge G Quintanilla (JG)

Advanced Development in Arrhythmia Mechanisms and Therapy Laboratory, Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC). Cardiovascular Institute, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

José Manuel Alfonso-Almazán (JM)

Advanced Development in Arrhythmia Mechanisms and Therapy Laboratory, Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Javier García (J)

Department of Cardiology, Hospital Universitario de Getafe, Madrid, Spain.

Luis Borrego (L)

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC). Cardiovascular Institute, Madrid, Spain.

Victoria Cañadas-Godoy (V)

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC). Cardiovascular Institute, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Nicasio Pérez-Castellano (N)

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC). Cardiovascular Institute, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Julián Pérez-Villacastín (J)

Fundación Interhospitalaria para la Investigación Cardiovascular (FIC), Madrid, Spain.
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC). Cardiovascular Institute, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Javier Jiménez-Díaz (J)

Department of Cardiology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.

José Jalife (J)

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Cardiac Arrhythmia Laboratory, Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

David Filgueiras-Rama (D)

Advanced Development in Arrhythmia Mechanisms and Therapy Laboratory, Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC). Cardiovascular Institute, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH